tradingkey.logo

GeneDx Holdings Corp

WGS
128.060USD
-2.290-1.76%
終値 11/14, 16:00ET15分遅れの株価
3.70B時価総額
1776.10直近12ヶ月PER

GeneDx Holdings Corp

128.060
-2.290-1.76%

詳細情報 GeneDx Holdings Corp 企業名

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.

GeneDx Holdings Corpの企業情報

企業コードWGS
会社名GeneDx Holdings Corp
上場日Sep 04, 2020
最高経営責任者「CEO」Ms. Katherine A. Stueland
従業員数1000
証券種類Ordinary Share
決算期末Sep 04
本社所在地333 Ludlow Street
都市STAMFORD
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号06902
電話番号18887291206
ウェブサイトhttps://sema4.com/
企業コードWGS
上場日Sep 04, 2020
最高経営責任者「CEO」Ms. Katherine A. Stueland

GeneDx Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
+9.73%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
+9.73%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%

株主

更新時刻: 4 hours ago
更新時刻: 4 hours ago
株主統計
種類
株主統計
株主統計
比率
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
他の
64.83%
株主統計
株主統計
比率
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
他の
64.83%
種類
株主統計
比率
Hedge Fund
36.29%
Investment Advisor/Hedge Fund
35.91%
Investment Advisor
30.37%
Corporation
10.65%
Research Firm
6.55%
Individual Investor
1.62%
Pension Fund
0.78%
Venture Capital
0.54%
Bank and Trust
0.49%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
446
32.52M
112.51%
-918.42K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Corvex Management LP
3.06M
10.65%
--
--
Aug 22, 2025
Casdin Capital, LLC
3.05M
10.6%
-461.51K
-13.16%
Aug 22, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.78%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.77%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.28M
4.45%
+241.28K
+23.25%
Jun 30, 2025
William Blair Investment Management, LLC
1.63M
5.68%
+442.41K
+37.21%
Jun 30, 2025
Pentwater Capital Management LP
1.22M
4.25%
+1.19M
+3712.50%
Jun 30, 2025
The Vanguard Group, Inc.
1.18M
4.09%
+148.96K
+14.50%
Jun 30, 2025
Goldman Sachs & Company, Inc.
973.26K
3.39%
-59.05K
-5.72%
Jun 30, 2025
Oracle Investment Management, Inc.
922.45K
3.21%
-47.50K
-4.90%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Global X Genomics & Biotechnology ETF
3.13%
Franklin Genomic Advancements ETF
2.07%
SPDR S&P Health Care Services ETF
1.66%
Simplify Health Care ETF
1.31%
Innovator IBD 50 Fund ETF
1.27%
Harbor Health Care ETF
1.27%
Invesco Dorsey Wright Healthcare Momentum ETF
1%
Main Thematic Innovation ETF
0.8%
First Trust Small Cap Growth AlphaDEX Fund
0.65%
ARK Genomic Revolution ETF
0.61%
詳細を見る
Global X Genomics & Biotechnology ETF
比率3.13%
Franklin Genomic Advancements ETF
比率2.07%
SPDR S&P Health Care Services ETF
比率1.66%
Simplify Health Care ETF
比率1.31%
Innovator IBD 50 Fund ETF
比率1.27%
Harbor Health Care ETF
比率1.27%
Invesco Dorsey Wright Healthcare Momentum ETF
比率1%
Main Thematic Innovation ETF
比率0.8%
First Trust Small Cap Growth AlphaDEX Fund
比率0.65%
ARK Genomic Revolution ETF
比率0.61%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
日付
種類
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
KeyAI